Clinical Trial Update: Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the bioavailability of Naproxen 500 mg across three formulations; the study sponsored by POZEN has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis

Drugs mentioned

• Naproxen 500 mg (naproxen)

Snippet

Sponsor: POZEN | Conditions: Arthritis | Phase 1 | Status: COMPLETED